Search research articles
Contact Us
Filters
Showing results (551-560 of 899) with videos related to
Page
of 90
Sort By:
Blood
|
August 1, 1990
Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs
F G Schuening, R Storb, S Goehle, et al.
Blood
|
April 1, 1979
Analysis of late infections in 89 long-term survivors of bone marrow transplantation
K Atkinson, R Storb, R L Prentice, et al.
Bone Marrow Transplantation
|
July 1, 1989
Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission
W Bensinger, F B Petersen, M Banaji, et al.
Blood
|
October 1, 1986
Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors
R F Raff, H J Deeg, T P Loughran, et al.
The American Journal of Pediatric Hematology/Oncology
|
February 1, 1994
Marrow transplant experience for children with severe aplastic anemia
J E Sanders, R Storb, C Anasetti, et al.
Blood
|
March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor
W I Bensinger, C H Weaver, F R Appelbaum, et al.
Human Gene Therapy
|
January 1, 1996
Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors
H P Kiem, B Darovsky, C Von Kalle, et al.
Bone Marrow Transplantation
|
April 1, 1996
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation
C Yu, R Storb, H J Deeg, et al.
Bone Marrow Transplantation
|
March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels
T Demirer, C D Buckner, F R Appelbaum, et al.
Blood
|
October 27, 1998
Methods for assessment of graft-versus-host disease
P J Martin, G Schoch, T Gooley, et al.
Page
of 90
Search research articles
Search
Showing results (551-560 of 899) with videos related to
Sort By:
Page
of 90
Blood
|
August 1, 1990
Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs
F G Schuening, R Storb, S Goehle, et al.
Blood
|
April 1, 1979
Analysis of late infections in 89 long-term survivors of bone marrow transplantation
K Atkinson, R Storb, R L Prentice, et al.
Bone Marrow Transplantation
|
July 1, 1989
Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission
W Bensinger, F B Petersen, M Banaji, et al.
Blood
|
October 1, 1986
Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors
R F Raff, H J Deeg, T P Loughran, et al.
The American Journal of Pediatric Hematology/Oncology
|
February 1, 1994
Marrow transplant experience for children with severe aplastic anemia
J E Sanders, R Storb, C Anasetti, et al.
Blood
|
March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor
W I Bensinger, C H Weaver, F R Appelbaum, et al.
Human Gene Therapy
|
January 1, 1996
Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors
H P Kiem, B Darovsky, C Von Kalle, et al.
Bone Marrow Transplantation
|
April 1, 1996
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation
C Yu, R Storb, H J Deeg, et al.
Bone Marrow Transplantation
|
March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels
T Demirer, C D Buckner, F R Appelbaum, et al.
Blood
|
October 27, 1998
Methods for assessment of graft-versus-host disease
P J Martin, G Schoch, T Gooley, et al.
Page
of 90